Jin Medical International Ltd.
ZJYL
$0.34
$0.00-0.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -104.96% | -104.96% | 77.33% | 77.33% | 1.56% |
| Total Depreciation and Amortization | 20.93% | 20.93% | 59.78% | 59.78% | 47.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 137.64% | 137.64% | -529.79% | -529.79% | -167.58% |
| Change in Net Operating Assets | 236.41% | 236.41% | -285.29% | -285.29% | -381.29% |
| Cash from Operations | 5,024.00% | 5,024.00% | -446.39% | -446.39% | -98.18% |
| Capital Expenditure | -2,353.59% | -2,353.59% | 40.58% | 40.58% | -660.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | 100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 59.72% | 59.72% | -841.02% | -841.02% | 42.43% |
| Cash from Investing | -0.95% | -0.95% | -717.31% | -717.31% | 41.34% |
| Total Debt Issued | 65.73% | 65.73% | 164.45% | 164.45% | 297.24% |
| Total Debt Repaid | -- | -- | 3.56% | 3.56% | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -96.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.37% | -18.37% | 575.11% | 575.11% | -25.87% |
| Foreign Exchange rate Adjustments | -789.60% | -789.60% | 185.74% | 185.74% | -66.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.99% | 53.99% | 57.89% | 57.89% | -50.01% |